Innovative Medical
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Innovative Medical sits in the top decile of US sponsors by registered trial count (#407 of 15,742 sponsors by registered trial count).
Innovative Medical: 44 sponsored US clinical trials, none currently recruiting.
Innovative Medical sponsors 44 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 43 completed. 41 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataracts, with 3 trials.
Top-decile sponsor footprint
Innovative Medical ranks in the top decile of sponsors by registered trial count (#407 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
43 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
44 total, page 1 of 1
Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial
NCT01279031
Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery
NCT01383057
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
NCT01298973
Laser Cataract Surgery With the Femtosecond Laser Technology
NCT01382823
Prospective Evaluation of Visual Outcomes With Tecnis One-Piece Multifocal Intraocular Lenses Compared With Patients Previously Implanted With Crystalens Aspheric Optic (AO)
NCT01191229
Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses
NCT01061281
Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence
NCT01191502
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268
Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik Procedure
NCT01061294
An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients
NCT01173198
An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses
NCT01004549
Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses
NCT01061918
Prospective Health Assessment of Cataract Patients' Ocular Surface
NCT01016405
Topical Cyclosporine and Disease Progression
NCT00567983
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
NCT00567177
An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
NCT00492479
Oasys vs. Extreme H20 Xtra 59
NCT00477763
Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes
NCT00469573
Refractive Surgery and Optive Compatibility Study
NCT00469157
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690
Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars
NCT00450775
Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00405457
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
NCT00349440
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
NCT00347841
Ketorolac vs. Steroid in the Prevention of CME
NCT00348244
Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens Patients
NCT00519948
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
NCT00348023
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
NCT00383396
Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
NCT00483795
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
NCT00377546
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00433225
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
NCT00347802
Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness
NCT00469521
Cross-Over Evaluation of Two Lubricating Eye Drops
NCT00493662
Comparison of Frequency of Use of Optive and Systane
NCT00406510
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00349583
Therapeutic Variables in Cataract Surgery
NCT00407017
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
NCT00348582
Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients
NCT00518700
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
NCT00348062
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
NCT00348400
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
NCT00347503
A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
NCT00399230
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 41 |
Therapeutic Areas
How the Innovative Medical archive is shaped
44 indexed studies, none listed as recruiting (0% open); 43 completed (98%).
Phase mix: 41 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Cataracts (3 trials), 6 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Innovative Medical: archived-pipeline peers nationwide
Peers matched on 44 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Innovative Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 44 archived trials
- Agios Pharmaceuticals · 44 trials · 7% recruiting
- Beth Israel Medical Center · 44 trials · 0% recruiting
- Kowa Research Institute · 44 trials · 0% recruiting
- Medtronic Cardiovascular · 44 trials · 9% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Innovative Medical page
44 registered trials is a research-attention snapshot, not an endorsement of Innovative Medical or any single study.
- None of Innovative Medical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cataracts is the condition Innovative Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataracts trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Innovative Medical pipeline card: 44 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.